Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2011

01.09.2011

Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation

verfasst von: Karen L. Syrjala, Allison C. Stover, Jean C. Yi, Samantha B. Artherholt, Eleni M. Romano, Gary Schoch, Susan Stewart, Mary E. D. Flowers

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The Internet provides a widely accessible modality for meeting survivorship care needs of cancer survivors. In this paper, we describe the development and implementation of an Internet site designed as a base from which to conduct a randomized controlled trial to meet psycho-educational needs of hematopoietic stem cell transplantation (HSCT) survivors.

Methods

A cross-disciplinary team designed, wrote content, and programmed an Internet site for online study registration, consent, assessment, and study implementation. All survivors who were 3–18 years after HSCT for hematologic malignancy and treated at one transplant center were approached by mail for participation. All study activities could be conducted without study staff contact. However, participants had options for phone or email contact with study staff as desired.

Results

Of 1,775 participants approached for the study, 775 (58% of those eligible) consented and completed baseline assessment. Mean age was 51.7 (SD, 12.5; age range, 18–79 years), with 56% male. Fifty-seven percent required staff contact one or more times; a majority were for minor technical issues or delays in completion of enrollment or baseline assessment.

Discussions/conclusions

This study demonstrated the potential for providing Internet-based survivorship care to long-term survivors of HSCT. Although building a survivorship Internet site requires a team with diverse expertise, once built, these resources can be implemented rapidly with large numbers of survivors.

Implications for cancer survivors

While Internet-based services will not meet all the needs of cancer survivors, this methodology represents an important modality for augmenting onsite clinical services as a method for meeting psycho-educational, information, and resource needs of cancer survivors.
Literatur
1.
Zurück zum Zitat Committee on Cancer Survivorship: Improving Care and Quality of Life. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2005. Committee on Cancer Survivorship: Improving Care and Quality of Life. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2005.
2.
Zurück zum Zitat Chow EJ, Mueller BA , Baker KS, Cushing-Haugen KL, Flowers MED, Martin PJ. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Annals of Internal Medicine. 2011. Chow EJ, Mueller BA , Baker KS, Cushing-Haugen KL, Flowers MED, Martin PJ. Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Annals of Internal Medicine. 2011.
3.
Zurück zum Zitat Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMedCrossRef Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMedCrossRef
4.
Zurück zum Zitat Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 2007;109:1765–72.PubMedCrossRef Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood. 2007;109:1765–72.PubMedCrossRef
5.
Zurück zum Zitat Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.PubMedCrossRef Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.PubMedCrossRef
6.
Zurück zum Zitat Stricker CT, Jacobs LA. Physical late effects in adult cancer survivors. Oncol Nurse Edition. 2008;22:33–41. Stricker CT, Jacobs LA. Physical late effects in adult cancer survivors. Oncol Nurse Edition. 2008;22:33–41.
7.
Zurück zum Zitat Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007;25:2709–18.PubMedCrossRef Demark-Wahnefried W, Clipp EC, Lipkus IM, Lobach D, Snyder DC, Sloane R, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007;25:2709–18.PubMedCrossRef
8.
Zurück zum Zitat Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. NEJM. 2006;355:1572–82.PubMedCrossRef Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. NEJM. 2006;355:1572–82.PubMedCrossRef
9.
Zurück zum Zitat Martin PJ, Counts GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol. 2010;28:1011–6.PubMedCrossRef Martin PJ, Counts GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol. 2010;28:1011–6.PubMedCrossRef
10.
Zurück zum Zitat Rizzo JD, Wingard JR, Tichelli A, Lee SJ, van Lint MT, Burns LJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006;12:138–51.PubMedCrossRef Rizzo JD, Wingard JR, Tichelli A, Lee SJ, van Lint MT, Burns LJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006;12:138–51.PubMedCrossRef
11.
Zurück zum Zitat Lowe T, Bhatia S, Somlo G. Second malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2007;13:1121–34.PubMedCrossRef Lowe T, Bhatia S, Somlo G. Second malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2007;13:1121–34.PubMedCrossRef
12.
Zurück zum Zitat Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 2007;110:3463–71.PubMedCrossRef Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 2007;110:3463–71.PubMedCrossRef
13.
Zurück zum Zitat Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291:2335–43.PubMedCrossRef Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291:2335–43.PubMedCrossRef
14.
Zurück zum Zitat Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–606.PubMedCrossRef Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–606.PubMedCrossRef
15.
Zurück zum Zitat Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23:599–608.PubMedCrossRef Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005;23:599–608.PubMedCrossRef
16.
Zurück zum Zitat Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant. 2004;34:257–66.PubMedCrossRef Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant. 2004;34:257–66.PubMedCrossRef
17.
Zurück zum Zitat Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the bone marrow transplant survivor study. Blood. 2004;104:1898–906.PubMedCrossRef Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the bone marrow transplant survivor study. Blood. 2004;104:1898–906.PubMedCrossRef
18.
Zurück zum Zitat Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A, et al. Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood. 2008;111:1740–1.PubMedCrossRef Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A, et al. Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood. 2008;111:1740–1.PubMedCrossRef
19.
Zurück zum Zitat Majhail NS, Ness KK, Burns LJ, Sun CL, Carter A, Francisco L, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13:1153–9.PubMedCrossRef Majhail NS, Ness KK, Burns LJ, Sun CL, Carter A, Francisco L, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13:1153–9.PubMedCrossRef
20.
Zurück zum Zitat Ness KK, Wall MM, Oakes JM, Robison LL, Gurney JG. Physical performance limitations and participation restrictions among cancer survivors: a population-based study. Ann Epidemiol. 2006;16:197–205.PubMedCrossRef Ness KK, Wall MM, Oakes JM, Robison LL, Gurney JG. Physical performance limitations and participation restrictions among cancer survivors: a population-based study. Ann Epidemiol. 2006;16:197–205.PubMedCrossRef
21.
Zurück zum Zitat Sweeney C, Schmitz KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst. 2006;98:521–9.PubMedCrossRef Sweeney C, Schmitz KH, Lazovich D, Virnig BA, Wallace RB, Folsom AR. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst. 2006;98:521–9.PubMedCrossRef
22.
Zurück zum Zitat Keating NL, Nørredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc. 2005;53:2145–52.PubMedCrossRef Keating NL, Nørredam M, Landrum MB, Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc. 2005;53:2145–52.PubMedCrossRef
23.
Zurück zum Zitat Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104:2557–64.PubMedCrossRef Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, et al. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104:2557–64.PubMedCrossRef
24.
Zurück zum Zitat Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA. 2003;290:1583–92.PubMedCrossRef Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, et al. Health status of adult long-term survivors of childhood cancer: a report from the childhood cancer survivor study. JAMA. 2003;290:1583–92.PubMedCrossRef
25.
Zurück zum Zitat Ness KK, Mertens AC, Hudson MM, Wall MM, Leisenring WM, Oeffinger KC, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med. 2005;143:639–47.PubMed Ness KK, Mertens AC, Hudson MM, Wall MM, Leisenring WM, Oeffinger KC, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med. 2005;143:639–47.PubMed
26.
Zurück zum Zitat Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 2005;105:4215–22.PubMedCrossRef Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 2005;105:4215–22.PubMedCrossRef
27.
Zurück zum Zitat Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784–92.PubMedCrossRef Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784–92.PubMedCrossRef
28.
Zurück zum Zitat Bradley L, Yaworsky PJ, Walsh FS. Myostatin as a therapeutic target for musculoskeletal disease. Cell Mol Life Sci. 2008;65:2119–24.PubMedCrossRef Bradley L, Yaworsky PJ, Walsh FS. Myostatin as a therapeutic target for musculoskeletal disease. Cell Mol Life Sci. 2008;65:2119–24.PubMedCrossRef
29.
Zurück zum Zitat Khera N, Chow EJ, Leisenring WM, Syrjala K.L., Baker KS, Flowers MED, et al. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2011 Khera N, Chow EJ, Leisenring WM, Syrjala K.L., Baker KS, Flowers MED, et al. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant. 2011
30.
Zurück zum Zitat Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant. 2010;16:207–14.PubMedCrossRef Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant. 2010;16:207–14.PubMedCrossRef
31.
Zurück zum Zitat Lee SJ, Leisenring WM, Khera N, et al. Utilization of preventive care services by hematopoietic cell transplant survivors [abstract]. Biol Blood Marrow Transplant. 2010;16:S226.CrossRef Lee SJ, Leisenring WM, Khera N, et al. Utilization of preventive care services by hematopoietic cell transplant survivors [abstract]. Biol Blood Marrow Transplant. 2010;16:S226.CrossRef
32.
Zurück zum Zitat Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK. Views of primary care providers on follow-up care of cancer patients. Fam Med. 2007;39:477–82.PubMed Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK. Views of primary care providers on follow-up care of cancer patients. Fam Med. 2007;39:477–82.PubMed
33.
Zurück zum Zitat Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive health communication applications for people with chronic disease. Cochrane Database of Systematic Reviews. 2005;CD004274. Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive health communication applications for people with chronic disease. Cochrane Database of Systematic Reviews. 2005;CD004274.
34.
Zurück zum Zitat Eysenbach G, Kummervold PE. “Is cybermedicine killing you?”—the story of a Cochrane disaster. J Med Internet Res. 2005;7:e21.PubMedCrossRef Eysenbach G, Kummervold PE. “Is cybermedicine killing you?”—the story of a Cochrane disaster. J Med Internet Res. 2005;7:e21.PubMedCrossRef
35.
Zurück zum Zitat Buis LR, Janney AW, Hess ML, Culver SA, Richardson CR. Barriers encountered during enrollment in an internet-mediated randomized controlled trial. Trials. 2009;10:76.PubMedCrossRef Buis LR, Janney AW, Hess ML, Culver SA, Richardson CR. Barriers encountered during enrollment in an internet-mediated randomized controlled trial. Trials. 2009;10:76.PubMedCrossRef
36.
Zurück zum Zitat Owen JE, Klapow JC, Roth DL, Shuster Jr JL, Bellis J, Meredith R, et al. Randomized pilot of a self-guided internet coping group for women with early-stage breast cancer. Ann Behav Med. 2005;30:54–64.PubMedCrossRef Owen JE, Klapow JC, Roth DL, Shuster Jr JL, Bellis J, Meredith R, et al. Randomized pilot of a self-guided internet coping group for women with early-stage breast cancer. Ann Behav Med. 2005;30:54–64.PubMedCrossRef
37.
Zurück zum Zitat Oenema A, Brug J, Dijkstra A, de Weerdt I, De Vries H. Efficacy and use of an internet-delivered computer-tailored lifestyle intervention, targeting saturated fat intake, physical activity and smoking cessation: a randomized controlled trial. Ann Behav Med. 2008;35:125–35.PubMedCrossRef Oenema A, Brug J, Dijkstra A, de Weerdt I, De Vries H. Efficacy and use of an internet-delivered computer-tailored lifestyle intervention, targeting saturated fat intake, physical activity and smoking cessation: a randomized controlled trial. Ann Behav Med. 2008;35:125–35.PubMedCrossRef
38.
Zurück zum Zitat Lorig KR, Ritter PL, Laurent DD, Plant K. Internet-based chronic disease self-management: a randomized trial. [Erratum appears in Med Care. 2007 Mar;45(3):276]. Med Care. 2006;44:964–71.PubMedCrossRef Lorig KR, Ritter PL, Laurent DD, Plant K. Internet-based chronic disease self-management: a randomized trial. [Erratum appears in Med Care. 2007 Mar;45(3):276]. Med Care. 2006;44:964–71.PubMedCrossRef
39.
Zurück zum Zitat RJ Van ’t, Crutzen R, De Vries H. Investigating predictors of visiting, using, and revisiting an online health-communication program: a longitudinal study. J Med Internet Res. 2010;12:e37. RJ Van ’t, Crutzen R, De Vries H. Investigating predictors of visiting, using, and revisiting an online health-communication program: a longitudinal study. J Med Internet Res. 2010;12:e37.
40.
Zurück zum Zitat Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: actualizing their potential. Annu Rev Public Health. 2009;30:273–92.PubMedCrossRef Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: actualizing their potential. Annu Rev Public Health. 2009;30:273–92.PubMedCrossRef
41.
Zurück zum Zitat Ahern NR. Using the Internet to conduct research. Nurse Res. 2005;13:55–70.PubMed Ahern NR. Using the Internet to conduct research. Nurse Res. 2005;13:55–70.PubMed
42.
Zurück zum Zitat Hanscom B, Lurie JD, Homa K, Weinstein JN. Computerized questionnaires and the quality of survey data. Spine. 2002;27:1797–801.PubMedCrossRef Hanscom B, Lurie JD, Homa K, Weinstein JN. Computerized questionnaires and the quality of survey data. Spine. 2002;27:1797–801.PubMedCrossRef
43.
Zurück zum Zitat Syrjala KL, Yi JC, Artherholt SB, Stover AC, Abrams JA. Measuring musculoskeletal symptoms in long-term cancer survivors who receive hematopoietic cell transplantation. J Cancer Surviv. 2010;4:225–35.PubMedCrossRef Syrjala KL, Yi JC, Artherholt SB, Stover AC, Abrams JA. Measuring musculoskeletal symptoms in long-term cancer survivors who receive hematopoietic cell transplantation. J Cancer Surviv. 2010;4:225–35.PubMedCrossRef
44.
Zurück zum Zitat Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho Oncol. 2009;18:113–27.CrossRef Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho Oncol. 2009;18:113–27.CrossRef
45.
Zurück zum Zitat Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer. 2011 Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer. 2011
46.
Zurück zum Zitat Syrjala KL, Kurland BF, Artherholt SB, Abrams JR, Langer SL. Five-year longitudinal evaluation of physical and psychological function in hematopoietic cell transplantation (HCT) survivors. Psycho Oncol. 2010;19:S2.CrossRef Syrjala KL, Kurland BF, Artherholt SB, Abrams JR, Langer SL. Five-year longitudinal evaluation of physical and psychological function in hematopoietic cell transplantation (HCT) survivors. Psycho Oncol. 2010;19:S2.CrossRef
47.
Zurück zum Zitat Loberiza Jr FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20:2118–26.PubMedCrossRef Loberiza Jr FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20:2118–26.PubMedCrossRef
48.
Zurück zum Zitat Rusiewicz A, DuHamel KN, Burkhalter J, Ostroff J, Winkel G, Scigliano E, et al. Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psycho Oncol. 2008;17:329–37.CrossRef Rusiewicz A, DuHamel KN, Burkhalter J, Ostroff J, Winkel G, Scigliano E, et al. Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psycho Oncol. 2008;17:329–37.CrossRef
49.
Zurück zum Zitat DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C, Meschian YM, et al. Randomized clinical trial of telephone-administered cognitive–behavioral therapy to reduce PTSD and distress symptoms after hematopoietic stem cell transplantation. J Clin Oncol. 2010;28:3754–61.PubMedCrossRef DuHamel KN, Mosher CE, Winkel G, Labay LE, Rini C, Meschian YM, et al. Randomized clinical trial of telephone-administered cognitive–behavioral therapy to reduce PTSD and distress symptoms after hematopoietic stem cell transplantation. J Clin Oncol. 2010;28:3754–61.PubMedCrossRef
50.
Zurück zum Zitat McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ, et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant. 1998;21:477–86.PubMedCrossRef McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ, et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant. 1998;21:477–86.PubMedCrossRef
51.
Zurück zum Zitat Syrjala KL, Abrams JR, Roth-Roemer SR, Dikmen S, Heiman J, Thomas AM. Efficacy of a randomized controlled trial (RCT) to enhance recovery from hematopoietic stem cell transplantation (HSCT) [abstract]. Psycho Oncol. 2004;13:397. Syrjala KL, Abrams JR, Roth-Roemer SR, Dikmen S, Heiman J, Thomas AM. Efficacy of a randomized controlled trial (RCT) to enhance recovery from hematopoietic stem cell transplantation (HSCT) [abstract]. Psycho Oncol. 2004;13:397.
52.
Zurück zum Zitat Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med. 1995;40:479–90.PubMedCrossRef Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med. 1995;40:479–90.PubMedCrossRef
53.
Zurück zum Zitat Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577–92.PubMedCrossRef Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577–92.PubMedCrossRef
54.
Zurück zum Zitat Devine EC. Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer. Oncol Nurs Forum Online. 2003;30:75–89.CrossRef Devine EC. Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer. Oncol Nurs Forum Online. 2003;30:75–89.CrossRef
55.
Zurück zum Zitat Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum. 1995;22:1369–81.PubMed Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum. 1995;22:1369–81.PubMed
56.
Zurück zum Zitat Vallance JK, Courneya KS, Plotnikoff RC, Mackey JR. Analyzing theoretical mechanisms of physical activity behavior change in breast cancer survivors: results from the activity promotion (ACTION) trial. Ann Behav Med. 2008;35:150–8.PubMedCrossRef Vallance JK, Courneya KS, Plotnikoff RC, Mackey JR. Analyzing theoretical mechanisms of physical activity behavior change in breast cancer survivors: results from the activity promotion (ACTION) trial. Ann Behav Med. 2008;35:150–8.PubMedCrossRef
57.
Zurück zum Zitat Reynolds KD, Buller DB, Yaroch AL, Maloy J, Geno CR, Cutter GR. Effects of program exposure and engagement with tailored prevention communication on sun protection by young adolescents. J Health Commun. 2008;13:619–36.PubMedCrossRef Reynolds KD, Buller DB, Yaroch AL, Maloy J, Geno CR, Cutter GR. Effects of program exposure and engagement with tailored prevention communication on sun protection by young adolescents. J Health Commun. 2008;13:619–36.PubMedCrossRef
58.
Zurück zum Zitat Nezu AM, Nezu CM, Perri MG. Problem-solving therapy for depression: theory, research, and clinical guidelines. New York, NY: Wiley; 1989. Nezu AM, Nezu CM, Perri MG. Problem-solving therapy for depression: theory, research, and clinical guidelines. New York, NY: Wiley; 1989.
59.
Zurück zum Zitat Oxman TE, Hegel MT, Hull JG, Dietrich AJ. Problem-solving treatment and coping styles in primary care for minor depression. J Consult Clin Psychol. 2008;76:933–43.PubMedCrossRef Oxman TE, Hegel MT, Hull JG, Dietrich AJ. Problem-solving treatment and coping styles in primary care for minor depression. J Consult Clin Psychol. 2008;76:933–43.PubMedCrossRef
60.
Zurück zum Zitat Leslie E, Marshall AL, Owen N, Bauman A. Engagement and retention of participants in a physical activity Website. Prev Med. 2005;40:54–9.PubMedCrossRef Leslie E, Marshall AL, Owen N, Bauman A. Engagement and retention of participants in a physical activity Website. Prev Med. 2005;40:54–9.PubMedCrossRef
61.
Zurück zum Zitat Joinson AN, Reips U. Personalized salutation, power of sender and response rates to Web-based surveys. Comput Hum Behav. 2007;23:1372–83.CrossRef Joinson AN, Reips U. Personalized salutation, power of sender and response rates to Web-based surveys. Comput Hum Behav. 2007;23:1372–83.CrossRef
62.
Zurück zum Zitat Mayer DK, Ratichek S, Berhe H, Stewart S, McTavish F, Gustafson D, et al. Development of a health-related Website for parents of children receiving hematopoietic stem cell transplant: HSCT-CHESS. J Cancer Surviv. 2010;4:67–73.PubMedCrossRef Mayer DK, Ratichek S, Berhe H, Stewart S, McTavish F, Gustafson D, et al. Development of a health-related Website for parents of children receiving hematopoietic stem cell transplant: HSCT-CHESS. J Cancer Surviv. 2010;4:67–73.PubMedCrossRef
Metadaten
Titel
Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation
verfasst von
Karen L. Syrjala
Allison C. Stover
Jean C. Yi
Samantha B. Artherholt
Eleni M. Romano
Gary Schoch
Susan Stewart
Mary E. D. Flowers
Publikationsdatum
01.09.2011
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2011
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-011-0182-x

Weitere Artikel der Ausgabe 3/2011

Journal of Cancer Survivorship 3/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.